Singapore - English - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - orthopaedics - the lcp pediatric condylar plate is intended for use in pedi¬atric patients up to adolescence and for small-stature adult patients. specific indications include: -fixed flexion contracture of knee in neurological conditions. -deformity correction in the distal femur. -rotational malalignment of the femur (if distal correction preferred). -supracondylar fractures of the femur.

Singapore - English - HSA (Health Sciences Authority)

somnotec (s) pte. ltd. - ear, nose & throat - based around a light and compact base, the stainless steel pediatric efer-dumon bronchoscope comprises 3 tracheal tubes and 3 ventilated bronchial tubes. these allows optmal efficiency of ventilation flux.

Singapore - English - HSA (Health Sciences Authority)

humedical (s) pte. ltd. - dental - indicated as a bone stabilizer and lengthening (transport or non-transport) device when correction of congenital deficiencies or post traumatic defects of the mandible (including ramus, body, symphisis), require gradual distraction. it is intended for use in pediatric population for children under 4 years of age, including infants and neonates. intended for single patient use only.

Singapore - English - HSA (Health Sciences Authority)

philips electronics singapore pte ltd - general hospital - the performax pediatric total face mask is intended to provide an interface for application of non-invasive positive airway pressure delivered to patients by a device such as a cpap or bi-level system. the mask is for single use / multiple use in the hospital/institutional environment only. the mask is to be used on patients 1 year or older (> 7 kg) for whom positive airway pressure therapy has been prescribed.

Singapore - English - HSA (Health Sciences Authority)

philips electronics singapore pte ltd - general hospital - the performax pediatric se total face mask is intended to provide a patient interface for application of noninvasive ventilation. the mask is to be used as an accessory to ventilators which have adequate alarms and safety systems for ventilator failure, and which are intended to administer cpap or positive pressure ventilation for treatment of respiratory failure, respiratory insufficiency, or obstructive sleep apnea. the mask is for multiple use /single use in the hospital/institutional environment only. the mask is to be used on patients 1 year or older (>7 kg) who are appropriate candidates for noninvasive ventilation.

Singapore - English - HSA (Health Sciences Authority)

resmed asia pte. ltd. - anaesthesiology - the pixi pediatric mask channels airflow noninvasively to a patient from a continuous positive airway pressure (cpap) or bilevel device (‘device’). it is: • to be used by children aged between 2 and 7 for whom continuous positive airway pressure (cpap) or bilevel therapy has been prescribed • intended for single-patient re-use in the home and single patient re-use in the hospital/institutional environment.

United States - English - NLM (National Library of Medicine)

green choice for life pediatric - guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq), dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots) - cough suppressant expectorant uses - temporarily relieves cough due to minor throat and bronchial irritation as may occur with the common cold and helps loosen phlegm (mucus) and thin bronchial sections to make coughs more productive. do not use - on child taking a prescription monoamine oxidase inhibitor (maoi) (certain drugs for depression, psychiatric, or emotional conditions, or parkinson’s disease), or for 2 weeks after stopping the maoi drug. if you do not know if your child's prescription drug contains an maoi, ask your doctor or pharmacist before taking this product. - if cough persists for more than one week, tends to recur, or is accompanied by fever, rash or persistent headache. a persisten coug may be a sign of a serious condition.

Malta - English - Medicines Authority

laboratorio de aplicaciones farmacodinamicas s.a. grassot, 16, 08025, barcelona, spain - ibuprofen - oral suspension - ibuprofen 20 mg - antiinflammatory and antirheumatic products

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - clindamycin palmitate hydrochloride (unii: vn9a8jm7m7) (clindamycin - unii:3u02el437c) - clindamycin palmitate hydrochloride for oral solution, usp (pediatric) (clindamycin palmitate hcl) is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. clindamycin is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci and staphylococci. its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. because of the risk of colitis, as described in the boxed warning , before selecting clindamycin the physician should consider the nature of the infection and the suitability of less toxic alternatives (e.g., erythromycin). anaerobes: serious respiratory tract infections such as empyema, anaerobic pneumonitis and lung abscess; serious skin and soft tissue infections; septicemia; intra-abdominal infections such as peritonitis and intra-abdominal abscess (typically resulting from anaerobic organisms resident in the normal gastrointestinal tract); infections of the female pelvis and genital tract such as endometritis, nongonococcal tubo-ovarian abscess, pelvic cellulitis and postsurgical vaginal cuff infection. streptococci: serious respiratory tract infections; serious skin and soft tissue infections. staphylococci: serious respiratory tract infections; serious skin and soft tissue infections. pneumococci: serious respiratory tract infections. bacteriologic studies should be performed to determine the causative organisms and their susceptibility to clindamycin. to reduce the development of drug-resistant bacteria and maintain the effectiveness of clindamycin palmitate hydrochloride for oral solution (pediatric) and other antibacterial drugs, clindamycin palmitate hydrochloride for oral solution (pediatric) should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. this drug is contraindicated in individuals with a history of hypersensitivity to preparations containing clindamycin or lincomycin.

Philippines - English - FDA (Food And Drug Administration)

taisho pharmaceuticals (philippines), inc. - ambroxol hydrochloride - pediatric drops - 7.5mg/ ml